FDA Warning Letter — Brandon Exxon Sprint Mart

Case 519875 — FEI 3013341267

The FDA took a Warning Letter action against Brandon Exxon Sprint Mart on Mar 16, 2017 (Brandon, MS). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Brandon Exxon Sprint Mart
Date
Mar 16, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Brandon, MS (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.